Arkansas passes law banning PBMs from owning pharmacies - Healthcare Dive
Arkansas law now prohibits Pharmacy Benefit Managers (PBMs) from owning pharmacies, impacting their operational structure and relationships with pharmacies.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on August 9, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All Pharmacy Benefit Managers (PBMs) operating in Arkansas. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate compliance required as the law is effective upon passage.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
New law bans PBMs from owning pharmacies, affecting their business model and pharmacy partnerships.
Who it affects
All Pharmacy Benefit Managers (PBMs) operating in Arkansas.
What you must do
Review ownership structures and divest from any pharmacy ownership to comply with the new law.
Deadline
Immediate compliance required as the law is effective upon passage.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant from Schedule IV into Schedule V
- FDA moves to expose hidden foreign drug factories, strengthen domestic production in sweeping rule proposal - foxbusiness.com
- The FDA let substandard factories ship these medications to the U.S. - michiganadvance.com
- Tom’s of Maine says it will remedy mold, bacteria problems found by FDA at Sanford plant - mainebiz.biz
- The FTC Challenges Companies’ Allegedly Improper Orange Book Patent Listings - skadden.com